Skip to main content

Table 1 Grouping and treatment of experimental pigs

From: Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China

Group

Vaccine

Vaccine dose (TCID50)

Vaccination day

Challenge dose (TCID50)

Challenge day

1

Live-attenuated PCV1-2b

2 × 103.5

21

2 × 104.8

49

2

Live-attenuated PCV1-2b

2 × 104.0

21

2 × 104.8

49

3

Inactivated PCV1-2b vaccine

2 × 105.0

21

2 × 104.8

49

4a

Inactivated PCV2b vaccine X

2 ml

21

2 × 104.8

49

5

Challenge without vaccination

-

-

2 × 104.8

49

6

Mock group

-

-

-

-

  1. aOne pig died after routine bleeding at 7 DPV due to massive hemorrhaging